Platelet activity and serum homocysteine levels in patients with end-stage renal failure with regard to dialysis modality

Renal Failure

Volumn 28, Issue 4, 2006, Pages 303-308

  Taskapan, Hulya ^a   Senel, Soner ^a   Ulutas, Ozkan ^a   Cagatay Taskapan, M ^a   Aksoy, Yuksel ^a   Kosar, Feridun ^a   Aydogdu, Ismet ^a   Sahin, Ibrahim ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

CD62P; Hemodialysis; Homocysteine; Left ventricular hypertrophy; Peritoneal dialysis; Platelet activity

Indexed keywords

CD42A ANTIGEN; CD61 ANTIGEN; FIBRINOGEN RECEPTOR; HOMOCYSTEINE; PADGEM PROTEIN; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOCOMPATIBILITY; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSIS; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; PERIPHERAL VASCULAR DISEASE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; TREATMENT DURATION;

AGED; ANALYSIS OF VARIANCE; FEMALE; HOMOCYSTEINE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; P-SELECTIN; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PLATELET ACTIVATION; RENAL DIALYSIS; STATISTICS, NONPARAMETRIC;

EID: 33745548414     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220600599019     Document Type: Article

References (38)

1. Busch M, Franke S, Muller A, Wolf M, Gerth J, Ott U, Niwa T, Stein G. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the Creactive protein. Kidney Int. 2004;66:338-347.
2. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Ritz E. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int. 1998;53:1343-1347.
3. Stam F, van Guldener C, Schalkwijk CG, ter Wee PM, Donker AJ, Stehouwer CD. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol. Dial. Transplant. 2003;18:892-898.
4. Parsons DS, Reaveley DA, Pavitt DV, Brown EA. Relationship of renal function to homocysteine and lipoprotein(a) levels: the frequency of the combination of both risk factors in chronic renal impairment. Am. J. Kidney Dis. 2002;40:916-923.
5. Zeller JA, Tschoepe D, Kessler C. Circulating platelets show increased activation in patients with acute cerebral ischemia. Thromb. Hemost. 1999;81:373-377.
6. Tschoepe D, Schhultheiss HP, Kolarov P, et al. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 1993;88:37-42.
7. Salvati F, Liani M. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis. Int. J. Artif. Organs 2001;24:131-135.
8. McEver RP, Martin MN. A monoclonal antibody to a membrane glycoprotein binds only to activated platelet. J. Biol. Chem. 1984;259:9799-9804.
9. Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J. Clin. Invest. 1979;64:1393-1401.
10. Spencer CG. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Int. J. Cardiol. 2004;94:293-300.
11. Riba R, Nicolaou A, Troxler M, Homer-Vaniasinkam S, Naseem KM. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels. Atherosclerosis 2004;175:69-75.
12. Buccianti G, Baragetti I, Bamonti F, Furiani S, Dorighet V, Patrosso C. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease. J. Nephrol. 2004;17:405-410.
13. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
14. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996;28:22-30.
15. Katopolis J, Kolodny L, Jy W, Horstman L, De Marchena E, Tao J, Haynes D, Ahn YS. Platelet microparticles and calcium homeostasis in acute coronary ischemias. Am. J. Hematol. 1997;54:95.
16. Nomura S, Kanazawa S, Fukuhara S. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. J. Hum. Hypertens. 2002;16:1345-1349.
17. Koksch M, Zeiger F, Wittig K, Siegemund A, Reininger CB, Pfeiffer D, Ruehlmann C. Coagulation, fibrinolysis and platelet P-selectin expression in peripheral vascular disease. Eur. J. Vasc. Endovasc. Surg. 2001;21:147-154.
18. Lee YJ, Jy W, Horstmann J, Janania Y, Reves RE, Ahn YS. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb. Res. 1994;72:295.
19. D'Elia JA, Weinrauch LA, Gleason RE, Lipinska I, Lipinski B, Lee AT, Tofler GH. Risk factors for thromboembolic events in renal failure. Int. J. Cardiol. 2005;11:19-25.
20. Ballow A, Gader AM, Huraib S, Al-Husaini K, Mutwalli A, Al-Wakeel J. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation. Platelets 2005;16:19-24.
21. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood 1996;88:3259-3287.
22. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer S, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992;59:848.
23. Merten M, Chow T, Hellums D, Thiagarajan P. A new role for p-selectin in shear-induced platelet aggregation. Circulation 2000;102:2045.
24. Freedman JE, Loscalzo J, Benoit SE, Valeri CR, Barrard MR, Michelson AD. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J. Clin. Invest. 1996;97:979.
25. Merten M, Thiagarajan P. P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation 2000;102:1931.
26. Frenette PS, Moyna C, Hartwell DW, Lowe JB, Hynes RO, Wagner DD. Platelet-endothelial interactions in inflamed mesenteric venules. Blood 1998;91:1318.
27. Gawaz MP, Mujais SK, Schmidt B, Gurland HJ. Platelet-leukocyte aggregation during hemodialysis. Kidney Int. 1994;46:489-495.
28. Stuard S, Carreno MP, Poignet JL, Albertazzi A, Haefner-Cavaillon N. A major role for CD62P/CD Ss interaction in leukocyte margination during hemodialysis. Kidney Int. 1995;48:93-102.
29. Cheung AK, Parker CJ, Hohnholt M. 02 Integrins are required for neutrophil degranulation induced by hemodialysis membranes. Kidney Int. 1993;43:649-660.
30. Faint RW. Platelet neutrophil interactions their significance. Blood Rev. 1992;6:83-91.
31. Ware JA, Heistad DD. Platelet endothelium interactions. N. Engl. J. Med. 1993;328:628-635.
32. Weinstein T, Fishman P, Djaldetti M, Levi J. Cytokine production by mononuclear cells from patients with chronic renal failure. Isr. J. Med. Sci. 1993;29:183-186.
33. Descamps-Latscha B, Herbelin A, Nguyen AT, de Groote D, Chauveau P, Verger C, Jungers P, Zingraff J. Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysis. Kidney Int. 1993;43:878-884.
34. Rabb H, Agosti SJ, Bittle PA, Fernandez M, Ramirez G, Tedder TF. Alterations in soluble and leukocyte surface L[selectin (CD 62L) in hemodialysis patients. J. Am. Soc. Nephrol. 1995;6:1445-1450.
35. Chuang YC, Chen JB, Yang LC, Kuo CY. Significance of platelet activation in vascular access survival of hemodialysis patients. Nephrol. Dial. Transplant. 2003;18:947-954.
36. Ashman N, Macey MG, Fan SL, Azam U, Yaqoob MM. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients. Nephrol. Dial. Transplant. 2003;18:2088-2096.
37. Yildiz A, et al. Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic hemodialysis patients. Nephrol. Dial. Transplant. 2005;20:760-767.
38. Schrenier R, Gobel-Schreiner B, Durst CH, Casper R, Walch S. Homocysteine: reference values. Clin. Lab. 1997;43:1121-1124.